Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Hospital of ChinaHKSE:03869 73 Days Payable is 115.92 as of Dec. 2025, which is 109% above its 10-year median of 55.44. GuruFocus rates HKSE:03869 with a GF Score™ of 73/100 and a GF Value™ of HK$5.53 (Possible Value Trap). The stock has 4 warning signs investors should review. Among 613 Healthcare Providers & Services companies, Hospital of China ranks better than 75.04% on this metric.
The historical rank and industry rank for Hospital of China's Days Payable or its related term are showing as below:
HKSE:03869'
s Days Payable Range Over the Past 10 Years
Min: 23.53 Med: 55.44 Max: 119.33
Current: 117.22
During the past 12 years, Hospital of China's highest Days Payable was 119.33. The lowest was 23.53. And the median was 55.44.
HKSE:03869's Days Payable is ranked better than 75.04% of 613
companies
in the Healthcare Providers & Services industry
Industry Median: 57.48
vs HKSE:03869: 117.22
Hospital of China's Days Payable
increased
from Dec. 2024 (80.13) to Dec. 2025 (115.92).
It may suggest that Hospital of Chinadelayed paying its suppliers.
The historical data trend for Hospital of China's Days Payable can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
HKSE:03869 vs HCA, THC, EHC: Days Payable Comparison
For the Medical Care Facilities subindustry, Hospital of China's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Hospital of China Days Payable vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Hospital of China's Days Payable distribution charts can be found below:
* The bar in red indicates where Hospital of China's Days Payable falls into.
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
Hospital of China's Days Payable for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Hospital of China (HKSE:03869) has a Days Payable of 115.92 as of Dec. 2025. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Hospital of China and its competitors. This is 109% above median its historical median of 55.44. Over the past decade, Hospital of China's Days Payable has ranged from 23.53 to 119.33. According to the industry distribution chart, Hospital of China ranks #153 out of 613 companies in the Healthcare Providers & Services industry, placing it in the top 25%.
Is Hospital of China's Days Payable too high?
Hospital of China's current Days Payable of 115.92 is 109% above median its 10-year median of 55.44. Over the past 10 years, this metric has ranged from a low of 23.53 to a high of 119.33. The Healthcare Providers & Services industry median Days Payable is 57.48. Hospital of China's value of 115.92 is 101.7% above this industry median. Based on the distribution chart, Hospital of China ranks #153 out of 613 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, Hospital of China has a GF Score™ of 73/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Hospital of China's Days Payable compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Hospital of China ranks #153 out of 613 companies for Days Payable. This places Hospital of China in the top 25% of its industry — outperforming the majority of peers. The industry median Days Payable is 57.48. Hospital of China's value of 115.92 is 101.7% above this benchmark. Historically, Hospital of China's own Days Payable has ranged from 23.53 to 119.33 over the past decade. While the company's 10-year median is 55.44 vs. the industry median of 57.48, Hospital of China has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Healthcare Providers & Services company?
The median Days Payable among Healthcare Providers & Services companies is 57.48, based on 613 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Hospital of China's current Days Payable of 115.92 is 101.7% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Hospital of China and its competitors. For the Healthcare Providers & Services industry, the median Days Payable is 57.48 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Hospital of China's current Days Payable is 115.92, which is 109% above median its own 10-year median of 55.44. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Hospital of China stock overvalued right now?
Based on GuruFocus' analysis, Hospital of China (HKSE:03869) is currently considered Possible Value Trap. The stock's GF Value™ is HK$5.53, compared to a current price of HK$3.40 — trading 38.5% below its estimated fair value. The current Days Payable is 115.92, which is 109% above median its 10-year median of 55.44 and 101.7% above the Healthcare Providers & Services industry median of 57.48. Hospital of China's overall GF Score™ is 73/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Hospital of China (HKSE:03869), the current Days Payable is 115.92 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Hospital of China (HKSE:03869) Overvalued in 2026?
Based on GuruFocus' analysis, Hospital of China stock appears to be undervalued.
The current stock price of HK$3.40 is trading 38.5% below its estimated GF Value™ of HK$5.53.
GuruFocus considers Hospital of China to be Possible Value Trap.
Key valuation signals for HKSE:03869:
Days Payable: 115.92 (109% above median its 10-year median of 55.44)
GF Value™: HK$5.53 vs. price of HK$3.40 (38.5% below fair value)
Industry Position: 101.7% above the Healthcare Providers & Services median (#153 of 613)
No single metric tells the full story. See the HKSE:03869 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Hospital Corporation of China Ltd is an investment holding company that operates and manages hospitals in the People's Republic of China. In addition to offering hospital management services, it also provides supply chain services, other ancillary services, and sells pharmaceutical products. The company has three operating segments, namely, Hospital management services, General hospital services, and the sale of pharmaceutical products. The General Hospital services segment is the primary revenue generator for the company. All the company's revenue is generates from PRC.
73GF Score
Get the complete analysis for HKSE:03869
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HKSE:03869 has been successfully added to your 
